![Jae-Joon Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jae-Joon Kim
Direktor/Vorstandsmitglied bei
YOUCEL, Inc.
Profil
Jae-Joon Kim currently works at Mirae Asset Venture Investment Co., Ltd., as Senior Managing Director, ImmunoMet Therapeutics, Inc., as Director from 2016, and YOUCEL, Inc., as Non-Executive Director.
Aktive Positionen von Jae-Joon Kim
| Unternehmen | Position | Beginn |
|---|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
 Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture invest in companies across the globe, particularly in South Korea. The firm targets companies operating in the nformation and communication, internet, biotechnology and environment sectors. It provides financing for early stage capital requirements and buyouts.. | Private Equity Investor | 01.01.2018 |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs for the treatment of cancer | Direktor/Vorstandsmitglied | 01.03.2016 |
YOUCEL, Inc.
 YOUCEL, Inc. BiotechnologyHealth Technology Develops bio-cellulose technology | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture invest in companies across the globe, particularly in South Korea. The firm targets companies operating in the nformation and communication, internet, biotechnology and environment sectors. It provides financing for early stage capital requirements and buyouts.. | Finance |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs for the treatment of cancer | Health Technology |
YOUCEL, Inc.
YOUCEL, Inc. BiotechnologyHealth Technology Develops bio-cellulose technology | Health Technology |
